2f3k
|
Substrate envelope and drug resistance: crystal structure of r01 in complex with wild-type hiv-1 protease
OverviewOverview
In our previous crystallographic studies of human immunodeficiency virus, type 1 (HIV-1) protease-substrate complexes, we described a conserved, "envelope" that appears to be important for substrate recognition and the, selection of drug-resistant mutations. In this study, the complex of HIV-1, protease with the inhibitor RO1 was determined and comparison with the, substrate envelope provides a rationale for mutational patterns.
About this StructureAbout this Structure
2F3K is a Single protein structure of sequence from Human immunodeficiency virus 1 with PO4 and RO1 as ligands. Active as HIV-1 retropepsin, with EC number 3.4.23.16 Full crystallographic information is available from OCA.
ReferenceReference
Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease., Prabu-Jeyabalan M, King NM, Nalivaika EA, Heilek-Snyder G, Cammack N, Schiffer CA, Antimicrob Agents Chemother. 2006 Apr;50(4):1518-21. PMID:16569872
Page seeded by OCA on Thu Nov 8 14:46:18 2007